Breaking News

Parexel Completes Strategic Separation

Aims to simplify and streamline business strategy and customer relationships while positioning both organizations for long-term growth.

By: Contract Pharma

Contract Pharma Staff

Parexel, a provider of drug development servicess from clinical through commercialization, has completed the separation of its Parexel Informatics and Medical Imaging business. The strategic move aims to simplify and streamline Parexel’s business strategy and customer relationships while positioning both organizations for continued, long-term growth. As part of the separation, Parexel Informatics will become Calyx.   Parexel will continue to leverage Calyx’s Medical Imaging, Clinical Trial Man...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters